Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Cylert

Known as: Abbott Brand of Pemoline 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2004
Review
2004
Attention-deficit/hyperactivity disorder (ADHD) is a risk factor for substance abuse in adults. Additional psychiatric… Expand
  • figure 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
2002
2002
OBJECTIVE To assess compliance with product labeling recommendations to use pemoline as second-line therapy for attention-deficit… Expand
Is this relevant?
2001
2001
This article examines the medical discourse that formed the foundations of what mental health professionals today call Attention… Expand
Is this relevant?
1998
1998
This investigation examined the efficacy of psychostimulant therapy in alleviating neurobehavioral dysfunction attendant to… Expand
  • table 1
Is this relevant?
1990
1990
Pemoline (Cylert) is an agent used to treat attention deficit disorders and other behavioral syndromes. There have, however, been… Expand
Is this relevant?
1989
1989
Methylphenidate (Ritalin) and pemoline (Cylert) are central nervous system stimulants which are widely prescribed for attention… Expand
Is this relevant?
1980
1980
An eight-week double-blind comparison between pemoline (Cylert), methylphenidate (Ritalin) hydrochloride, and placebo was carried… Expand
Is this relevant?
1973
1973
The purpose of this study was to determine the effects of magnesium pemoline (Cylert) and methylphenidate (Ritalin) on the memory… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
1968
1968
The authors report a preliminary study of the effects of Cylert (an equimolar compound of pemoline and magnesium hydroxide) on… Expand
Is this relevant?
1967
1967
SummaryThe effect of Cylert (pemoline with magnesium hydroxide) on learning and memory was tested by means of three different… Expand
  • table 1
  • table 3
Is this relevant?